Loading data for ELOX — first visit, this takes a few seconds.
Eloxx Pharmaceuticals Inc... (ELOX)
NasdaqCM: ELOX
· Real-Time Price · USD
15.07
-0.93 (-5.81%)
At close: Aug 28, 2026, 3:59 PM
15.36
+1.92%
After-hours: 7:53 PM
The price, the headline numbers and the latest news, in one place.
Eloxx Pharmaceuticals Inc. (ELOX) Stock Price, Analysis & Data
-5.81% (1D)
| Bid | 19.49 |
| Market Cap | 51.79M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -10.65M |
| -160692.25 | |
| 3.2 | |
| 4.71 | |
| -21.23 | |
| P/B (ttm) | 1.31 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 19.85 |
| Volume | 32,102 |
| Avg. Volume (20D) | 60,335 |
| Open | 16.22 |
| Previous Close | 16.00 |
| Day's Range | 15.07 - 16.65 |
| 52-Week Range | 8.20 - 23.40 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ELOX
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia. The company is developing exaluren, a eukaryotic ribosome-selective glycoside in a Phase 2 trial for the treatment of rare kidney diseases, including Alport syndrome with nonsense muta...
Industry Biotechnology
Sector Healthcare
IPO Date Jun 9, 2026
Employees 10
Stock Exchange NasdaqCM
Ticker Symbol ELOX
Website https://www.eloxxpharma.com
Financial Performance
In 2025, Eloxx Pharmaceuticals's revenue was 0, a decrease of -100% compared to the previous year's 6.36M. Earnings were -6M, an increase of 90.74%.
Financial StatementsEarnings Surprise
Eloxx Pharmaceuticals has released their quarterly earnings on Nov 13, 2023:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -14.41 exceeds estimates by 7.26, with 63.61% YoY growth.